Kortas-Stempak B - Search Results

1

Apo A-II participates in HDL-liposome interaction by the formation of new pre-β mobility particles and the modification of liposomes.

Wróblewska M, Czyżewska M, Wolska A, Kortas-Stempak B, Szutowicz A. Wróblewska M, et al. Biochim Biophys Acta. 2010 Dec;1801(12):1323-9. doi: 10.1016/j.bbalip.2010.08.005. Epub 2010 Aug 21. Biochim Biophys Acta. 2010. PMID: 20732453

2

Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles.

Wróblewska M, Kortas-Stempak B, Szutowicz A, Badzio T. Wróblewska M, et al. J Lipid Res. 2009 Apr;50(4):667-75. doi: 10.1194/jlr.M800399-JLR200. Epub 2008 Dec 9. J Lipid Res. 2009. PMID: 19066403 Free PMC article.

3

[Disturbances of lipoprotein metabolism in metabolic syndrome].

Czyzewska M, Wolska A, Cwiklińska A, Kortas-Stempak B, Wróblewska M. Czyzewska M, et al. Postepy Hig Med Dosw (Online). 2010 Jan 20;64:1-10. Postepy Hig Med Dosw (Online). 2010. PMID: 20093718 Free article. Review. Polish.

4

Interaction between VLDL and phosphatidylcholine liposomes generates new γ-LpE-like particles.

Ćwiklińska A, Kortas-Stempak B, Gliwińska A, Pacanis A, Kuchta A, Wróblewska M. Ćwiklińska A, et al. Lipids. 2014 Feb;49(2):143-53. doi: 10.1007/s11745-013-3861-8. Lipids. 2014. PMID: 24234844 Free PMC article.

5

[ApoE-containing HDL and the development of atherosclerosis].

Ćwiklińska A, Strzelecki A, Kortas-Stempak B, Zdrojewski Z, Wróblewska M. Ćwiklińska A, et al. Postepy Hig Med Dosw (Online). 2015 Jan 2;69:1-9. doi: 10.5604/17322693.1134724. Postepy Hig Med Dosw (Online). 2015. PMID: 25589708 Free article. Review. Polish.

6

The standardization of urine particle counting in medical laboratories--a Polish experience with the EQA programme.

Cwiklińska A, Kąkol J, Kuchta A, Kortas-Stempak B, Pacanis A, Rogulski J, Wróblewska M. Cwiklińska A, et al. Scand J Clin Lab Invest. 2012 Feb;72(1):52-8. doi: 10.3109/00365513.2011.628688. Epub 2011 Nov 16. Scand J Clin Lab Invest. 2012. PMID: 22087649

7

HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.

Kuchta A, Strzelecki A, Ćwiklińska A, Gruchała M, Zdrojewski Z, Kortas-Stempak B, Wieczorek E, Gliwińska A, Dąbkowski K, Jankowski M. Kuchta A, et al. J Cardiol. 2017 Mar;69(3):523-528. doi: 10.1016/j.jjcc.2016.04.007. Epub 2016 May 8. J Cardiol. 2017. PMID: 27169356 Free article.

8

Impact of phosphatidylcholine liposomes on the compositional changes of VLDL during lipoprotein lipase (LPL)-mediated lipolysis.

Ćwiklińska A, Gliwińska A, Senderowska Z, Kortas-Stempak B, Kuchta A, Dąbkowski K, Jankowski M. Ćwiklińska A, et al. Chem Phys Lipids. 2016 Feb;195:63-70. doi: 10.1016/j.chemphyslip.2015.12.007. Epub 2016 Jan 3. Chem Phys Lipids. 2016. PMID: 26756862

9

Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease.

Gliwińska A, Ćwiklińska A, Czaplińska M, Wieczorek-Breitzke E, Kortas-Stempak B, Kuchta A, Dębska-Ślizień A, Król E, Jankowski M. Gliwińska A, et al. Among authors: kortas stempak b. J Nephrol. 2023 Jan;36(1):115-124. doi: 10.1007/s40620-022-01412-y. Epub 2022 Aug 9. J Nephrol. 2023. PMID: 35943666 Free PMC article.

10

Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.

Ćwiklińska A, Cackowska M, Wieczorek E, Król E, Kowalski R, Kuchta A, Kortas-Stempak B, Gliwińska A, Dąbkowski K, Zielińska J, Dębska-Ślizień A, Jankowski M. Ćwiklińska A, et al. Kidney Blood Press Res. 2018;43(3):970-978. doi: 10.1159/000490686. Epub 2018 Jun 15. Kidney Blood Press Res. 2018. PMID: 29913451 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters